Atreca
Presence
Atreca is a company listed under the stock ticker BCEL (US).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Atreca
- John Orwin, Chief Executive Officer, President and Director
- Stacey Ma, Director
- Lindsey Rolfe, Director
Popular executive movements at Atreca
- Herb Cross, Chief Financial Officer, has left the company (posted on September 22 2023).
Create your alert
to follow the executive moves at Atreca.
Biotechnology
Atreca has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Atreca
- Atreca to Present at Upcoming Investor Conferences | Atreca
- Atreca Appoints Stephen Gould, Ph.D. as Chief Scientific Officer | Atreca
- Atreca Announces Corporate Reorganization to Extend Cash Runway | Atreca
- Atreca to Present at Upcoming Investor Conferences | Atreca
- Atreca Reports First Quarter 2022 Financial Results and Recent Corporate Developments | Atreca
- Atreca Announces Publication in PNAS: “Mobilization of Innate and Adaptive Antitumor Immune Responses by the RNP-Targeting Antibody ATRC-101” | Atreca
- Atreca to Present at Upcoming Virtual Investor Conferences | Atreca
- Atreca to Host Virtual R&D Day on Tuesday, April 5, 2022 | Atreca
- Atreca Announces Expansion of Preclinical Pipeline | Atreca
- Atreca to Present at Upcoming Virtual Investor Conferences | Atreca
- View more press releases Close
Social media about Atreca
- Atreca on Wikipedia, Google News & Yahoo Finance
- Atreca on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including John Orwin 
